DCC-2812 / Ono Pharma - LARVOL DELTA

Study of DCC-2812 in Participants With Advanced Genitourinary Cancers (clinicaltrials.gov) - P1 | N=60 | Recruiting | Sponsor: Deciphera Pharmaceuticals, LLC | Not yet recruiting ➔ Recruiting

Enrollment open • Monotherapy • Castration-Resistant Prostate Cancer • Genito-urinary Cancer • Oncology • Prostate Cancer • Renal Cell Carcinoma • Solid Tumor • Urothelial Cancer

Study of DCC-2812 in Participants With Advanced Genitourinary Cancers (clinicaltrials.gov) - P1 | N=60 | Not yet recruiting | Sponsor: Deciphera Pharmaceuticals, LLC

Monotherapy • New P1 trial • Castration-Resistant Prostate Cancer • Genito-urinary Cancer • Oncology • Prostate Cancer • Renal Cell Carcinoma • Solid Tumor • Urothelial Cancer